NOVOZYMES A/S-UNSPONS ADR - NVZMY
Detailed investor-level table based on 13F positions.
Early Q1 2026 data: only 1 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | History | Reduced | 10,013 | 637 | 0.0% | 0.0% | 1 | -219 | -2.14% | Q4 2025 | Feb 13, 2026 |
| Sterling Capital Management LLC | History | Reduced | 5,346 | 342 | 0.01% | 0.01% | 2 | -1,078 | -16.78% | Q4 2025 | Feb 13, 2026 |
| S&CO INC | History | No change | 4,500 | 288 | 0.02% | 0.02% | 3 | 0 | 0.0% | Q4 2025 | Feb 05, 2026 |
| GAMMA Investing LLC | History | Reduced | 2,275 | 144 | 0.01% | 0.01% | 4 | -126 | -5.25% | Q4 2025 | Jan 05, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | History | Reduced | 1,553 | 98 | 0.0% | 0.0% | 5 | -24 | -1.52% | Q4 2025 | Feb 06, 2026 |
| Salomon & Ludwin, LLC | History | Added to | 237 | 14 | 0.0% | 0.0% | 6 | +51 | 27.42% | Q4 2025 | Jan 28, 2026 |
| Ancora Advisors LLC | History | New | 157 | 9 | 0.0% | — | 7 | +157 | New | Q4 2025 | Feb 17, 2026 |
| Copeland Capital Management, LLC | History | No change | 49 | 3 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |
| Signature Equity Partners, LLC | History | New | 32 | 2 | 0.0% | — | 9 | +32 | New | Q4 2025 | Feb 17, 2026 |
| Boston Common Asset Management, LLC | History | Closed out | 0 | 0 | — | 0.01% | — | -4,625 | -100.0% | Q3 2025 | Oct 30, 2025 |
| IMA Advisory Services, Inc. | History | New | 15 | 0 | — | — | — | +15 | New | Q4 2025 | Feb 11, 2026 |
| AMERIFLEX GROUP, INC. | History | Reduced | 14 | 0 | — | 0.0% | — | -14 | -50.0% | Q4 2025 | Feb 18, 2026 |